QIAGEN N.V. (QGEN)
NL0015001WM6 - Common Stock
We assign a fundamental rating of 5 out of 10 to QGEN. QGEN was compared to 58 industry peers in the Life Sciences Tools & Services industry. QGEN has an excellent profitability rating, but there are some minor concerns on its financial health. QGEN has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
QGEN had positive earnings in the past year.
QGEN had a positive operating cash flow in the past year.
QGEN had positive earnings in 4 of the past 5 years.
Each year in the past 5 years QGEN had a positive operating cash flow.
1.2 Ratios
QGEN's Return On Assets of 5.80% is amongst the best of the industry. QGEN outperforms 84.21% of its industry peers.
QGEN has a Return On Equity of 9.36%. This is amongst the best in the industry. QGEN outperforms 80.70% of its industry peers.
The Return On Invested Capital of QGEN (7.47%) is better than 82.46% of its industry peers.
The Average Return On Invested Capital over the past 3 years for QGEN is in line with the industry average of 10.00%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.8% | ||
| ROE | 9.36% | ||
| ROIC | 7.47% |
ROA(3y)6.88%
ROA(5y)5.2%
ROE(3y)12.58%
ROE(5y)9.79%
ROIC(3y)9.15%
ROIC(5y)8.32%
1.3 Margins
QGEN's Profit Margin of 17.38% is amongst the best of the industry. QGEN outperforms 89.47% of its industry peers.
QGEN's Profit Margin has improved in the last couple of years.
QGEN has a better Operating Margin (22.75%) than 92.98% of its industry peers.
In the last couple of years the Operating Margin of QGEN has grown nicely.
QGEN's Gross Margin of 62.78% is amongst the best of the industry. QGEN outperforms 92.98% of its industry peers.
QGEN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.75% | ||
| PM (TTM) | 17.38% | ||
| GM | 62.78% |
OM growth 3Y-7.62%
OM growth 5Y3%
PM growth 3Y-3.3%
PM growth 5Y6.5%
GM growth 3Y-1.61%
GM growth 5Y-1.22%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), QGEN is creating some value.
Compared to 1 year ago, QGEN has more shares outstanding
The number of shares outstanding for QGEN has been increased compared to 5 years ago.
Compared to 1 year ago, QGEN has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.91 indicates that QGEN is not in any danger for bankruptcy at the moment.
The Altman-Z score of QGEN (3.91) is better than 70.18% of its industry peers.
QGEN has a debt to FCF ratio of 4.20. This is a neutral value as QGEN would need 4.20 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 4.20, QGEN is doing good in the industry, outperforming 77.19% of the companies in the same industry.
A Debt/Equity ratio of 0.25 indicates that QGEN is not too dependend on debt financing.
QGEN has a Debt to Equity ratio (0.25) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 4.2 | ||
| Altman-Z | 3.91 |
ROIC/WACC0.87
WACC8.6%
2.3 Liquidity
A Current Ratio of 1.84 indicates that QGEN should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.84, QGEN is doing worse than 64.91% of the companies in the same industry.
A Quick Ratio of 1.45 indicates that QGEN should not have too much problems paying its short term obligations.
QGEN has a worse Quick ratio (1.45) than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.84 | ||
| Quick Ratio | 1.45 |
3. Growth
3.1 Past
The earnings per share for QGEN have decreased by -2.13% in the last year.
The Earnings Per Share has been growing by 9.58% on average over the past years. This is quite good.
The Revenue has decreased by -2.99% in the past year.
QGEN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.53% yearly.
EPS 1Y (TTM)-2.13%
EPS 3Y-0.51%
EPS 5Y9.58%
EPS Q2Q%-12.51%
Revenue 1Y (TTM)-2.99%
Revenue growth 3Y1.66%
Revenue growth 5Y5.53%
Sales Q2Q%-5.48%
3.2 Future
Based on estimates for the next years, QGEN will show a small growth in Earnings Per Share. The EPS will grow by 7.75% on average per year.
The Revenue is expected to grow by 6.29% on average over the next years.
EPS Next Y1.44%
EPS Next 2Y4.98%
EPS Next 3Y6.63%
EPS Next 5Y7.75%
Revenue Next Year2.25%
Revenue Next 2Y4.26%
Revenue Next 3Y5.03%
Revenue Next 5Y6.29%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 21.43, the valuation of QGEN can be described as rather expensive.
QGEN's Price/Earnings ratio is rather cheap when compared to the industry. QGEN is cheaper than 98.25% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 24.41, QGEN is valued at the same level.
Based on the Price/Forward Earnings ratio of 18.83, the valuation of QGEN can be described as rather expensive.
91.23% of the companies in the same industry are more expensive than QGEN, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 20.59. QGEN is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.43 | ||
| Fwd PE | 18.83 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, QGEN is valued cheaper than 94.74% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, QGEN is valued cheaply inside the industry as 84.21% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.24 | ||
| EV/EBITDA | 14.8 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates QGEN does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of QGEN may justify a higher PE ratio.
PEG (NY)14.91
PEG (5Y)2.24
EPS Next 2Y4.98%
EPS Next 3Y6.63%
5. Dividend
5.1 Amount
QGEN has a Yearly Dividend Yield of 3.18%. Purely for dividend investing, there may be better candidates out there.
QGEN's Dividend Yield is rather good when compared to the industry average which is at 0.67. QGEN pays more dividend than 100.00% of the companies in the same industry.
QGEN's Dividend Yield is a higher than the S&P500 average which is at 2.30.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.18% |
5.2 History
QGEN does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y4.98%
EPS Next 3Y6.63%
QIAGEN N.V.
NYSE:QGEN (7/26/2024, 7:04:00 PM)
After market: 43.94 0 (0%)43.94
+1.7 (+4.02%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap9.75B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.18% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.43 | ||
| Fwd PE | 18.83 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)14.91
PEG (5Y)2.24
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.8% | ||
| ROE | 9.36% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 22.75% | ||
| PM (TTM) | 17.38% | ||
| GM | 62.78% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.84 | ||
| Quick Ratio | 1.45 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-2.13%
EPS 3Y-0.51%
EPS 5Y
EPS Q2Q%
EPS Next Y1.44%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-2.99%
Revenue growth 3Y1.66%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y